The goal of the present study is to determine the expression profile of steroid sulfatase (STS), and the androgen receptor (AR) in the serous, endometrioid and mucinous histological subtypes of ovarian tumors in order to provide evidence of their relevance as a risk factor in overall patient survival. The gene discussed is STS; the disease is ovarian neoplasm.